PROSTATE CA
Clinical trials for PROSTATE CA explained in plain language.
Never miss a new study
Get alerted when new PROSTATE CA trials appear
Sign up with your email to follow new studies for PROSTATE CA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could two radiation doses beat five for prostate cancer?
Disease control Recruiting nowThis phase 2 trial tests whether giving prostate cancer radiation in just 2 sessions is as safe and effective as the standard 5-session approach. About 100 men with low- or intermediate-risk prostate cancer will be randomly assigned to one of the two schedules. Both groups will u…
Matched conditions: PROSTATE CA
Phase: PHASE2 • Sponsor: British Columbia Cancer Agency • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New drug cocktail aims to shrink prostate tumors before surgery
Disease control Recruiting nowThis early-phase trial is testing whether a combination of two hormone-blocking drugs (darolutamide and relugolix) can safely shrink high-risk prostate tumors before they are surgically removed. About 30 men with aggressive prostate cancer will take the drugs for a short time bef…
Matched conditions: PROSTATE CA
Phase: PHASE1 • Sponsor: AdventHealth • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
Triple-Drug attack before prostate surgery shows promise in early trial
Disease control Recruiting nowThis study tests whether adding two drugs—fasudil hydrochloride and a PD-1 inhibitor—to standard hormone therapy before prostate cancer surgery can better shrink or eliminate tumors. About 83 men with locally advanced or limited metastatic prostate cancer will receive either the …
Matched conditions: PROSTATE CA
Phase: PHASE2, PHASE3 • Sponsor: baotai Liang • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New combo therapy aims to wipe out prostate tumors before surgery
Disease control Recruiting nowThis Phase 2 trial tests whether adding homoharringtonine, a drug from a plant, to standard hormone therapy can better shrink or eliminate prostate cancer before surgery. About 96 men with locally advanced or limited spread prostate cancer will receive either the drug combo or a …
Matched conditions: PROSTATE CA
Phase: PHASE2 • Sponsor: baotai Liang • Aim: Disease control
Last updated Jun 26, 2026 14:51 UTC
-
Could a menopause drug cool hot flashes in men with prostate cancer?
Symptom relief Recruiting nowThis study tests a drug called fezolinetant, already approved for hot flashes in menopausal women, to see if it can reduce hot flashes in men with prostate cancer who are on hormone-lowering therapy. About 32 men will take the drug daily for 28 days. The goal is to measure how mu…
Matched conditions: PROSTATE CA
Phase: PHASE2 • Sponsor: University of Vermont • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
New study aims to improve prostate cancer detection for trans community
Knowledge-focused Recruiting nowThis study is figuring out what normal PSA levels are for trans women and non-binary people who have a prostate. Researchers will measure PSA in 500 volunteers aged 40 and older who are on hormones or have had lower surgery. The goal is to help doctors better detect prostate canc…
Matched conditions: PROSTATE CA
Sponsor: Queen Mary University of London • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:03 UTC